Equity Capital Markets

Company · CIK 1382101

SUTRO BIOPHARMA, INC.

CIK1382101 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Business addressCA
ListedSTRO (Nasdaq)
First annual or quarterly report2018-11-14

Offerings

5 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-294541
ShelfEffective
 2026-03-232026-04-012
333-275525
ShelfEffective
 2023-11-132026-02-105
333-255014
ShelfEffective
 2021-04-022022-05-192
333-234101
ShelfEffective
 2019-10-042020-12-097
333-227103
IPOFinal prospectus
 2018-08-292018-09-274

Filings

21
FiledFilingRegistrationAccession
2026-04-01EFFECTDeclared effective 333-2945419999999995-26-001050
2026-03-23S-3Shelf registered 333-2945410001193125-26-120004
2026-02-10424B5Shelf takedown 333-2755250001193125-26-044923
2024-04-02424B5Shelf takedown 333-2755250001193125-24-084879
2024-02-09424B5Shelf takedown 333-2755250001193125-24-030080
2023-11-21EFFECTDeclared effective 333-2755259999999995-23-003414
2023-11-13S-3Shelf registered 333-2755250001193125-23-276208
2022-05-19EFFECTDeclared effective 333-2550149999999995-22-001527
2021-04-02S-3ASRShelf registered 333-2550140001193125-21-105216
2020-12-09424B5Shelf takedown 333-2341010001193125-20-313802
2020-12-07424B5Shelf takedown 333-2341010001193125-20-311750
2020-05-12424B5Shelf takedown 333-2341010001193125-20-140570
2020-05-11424B5Shelf takedown 333-2341010001193125-20-139053
2019-10-11EFFECTDeclared effective 333-2341019999999995-19-002305
2019-10-11424B5Shelf takedown 333-2341010001193125-19-266765
2019-10-04S-3Shelf registered 333-2341010001193125-19-262726
2018-09-27424B4Final prospectus 333-2271030001193125-18-285823
2018-09-26EFFECTDeclared effective 333-2271039999999995-18-002466
2018-09-17S-1/AAmendment 333-2271030001193125-18-274668
2018-08-29S-1Registration filed 333-2271030001193125-18-262012
2018-06-01DRSDraft made public 377-020990000950123-18-006099

All filings of this company · CSV